Airway and Anesthesia Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Airway and Anesthesia Devices Pipeline Product Market Report Overview

Airway and Anesthesia Devices are single-use devices used in conjunction with anesthesia equipment to administer anesthesia. The Airway and Anesthesia Devices pipeline market research report provides comprehensive information about the Airway and Anesthesia Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Airway and Anesthesia Devices Pipeline Products Market Segmentation by Territories

Some of the key territories with products in the pipeline are the US, China, Colombia, Europe, Canada, Italy, Oman, Poland, Switzerland, the UAE, and the UK. As of December 2022, the US has the highest number of products in the pipeline out of them all.

Airway and Anesthesia Devices Pipeline Products Market Analysis, by Territories, 2022 (%)

Airway and Anesthesia Devices Pipeline Products Market Analysis, by Territories

For more territory insights into the Airway and Anesthesia Devices pipeline products market, download a free report sample

Airway and Anesthesia Devices Pipeline Products Market Segmentation by Key Regulatory Paths

The key regulatory paths followed by the Airway and Anesthesia Devices pipeline products market are 510(k), CE, NMPA, UKCA, EUA, INVIMA, and MDL. Most of the products follow the 510(k) pathway to enter the market.

Airway and Anesthesia Devices Pipeline Products Market Analysis, by Regulatory Paths, 2022 (%)

Airway and Anesthesia Devices Pipeline Products Market Analysis, by Regulatory Paths

For more Airway and Anesthesia Devices pipeline products regulatory path insights, download a free report sample

Airway and Anesthesia Devices Pipeline Products Market - Competitive Landscape

Some of the leading companies in the Airway and Anesthesia Devices pipeline products market are Adroit USA, Inc, Airway Innovations LLC, Cryofocus Medtech Shanghai Co Ltd, DMF Medical Inc, Drexel University, H. Lee Moffitt Cancer Center & Research Institute Inc, Johns Hopkins University, Medical Device Investments, Inc., Rutgers the State University of New Jersey, and Sedana Medical AB.

Cryofocus Medtech Shanghai Co Ltd: It is a medical device company that engages in the research, development, and manufacturing of cryoablation systems for cardiovascular interventional therapy. Cryofocus Medtech is headquartered in Shanghai, China.

Drexel University: It is a research university which provides educational degrees and research programs. The university offers courses for undergraduate courses, graduate and professional courses, adult education programs, colleges and schools, libraries, and online training services. Drexel is headquartered in Philadelphia, Pennsylvania, the US.

H. Lee Moffitt Cancer Center & Research Institute Inc: It is a healthcare service provider that offers medical services such as surgical care, fertility preservation, radiation therapy, interventional radiology, rehabilitation services, chemotherapy, cardio-oncology, blood and bone marrow transplant, cancer survivorship clinic, tumor board, interventional pain management, supportive care medicine, survivorship program, clinical trials, and others. Moffitt is headquartered in Tampa, Florida, the US.

Airway and Anesthesia Devices Pipeline Products Market Report Overview

Key Territories The US, China, Colombia, Europe, Canada, Italy, Oman, Poland, Switzerland, the UAE, and the UK
Key Regulatory Paths 510(k), CE, NMPA, UKCA, EUA, INVIMA, and MDL
Leading Companies Adroit USA, Inc, Airway Innovations LLC, Cryofocus Medtech Shanghai Co Ltd, DMF Medical Inc, Drexel University, H. Lee Moffitt Cancer Center & Research Institute Inc, Johns Hopkins University, Medical Device Investments, Inc., Rutgers the State University of New Jersey, and Sedana Medical AB

Segments Covered in the Report

Airway and Anesthesia Devices Pipeline Products Market Territories Outlook

  • The US
  • China
  • Colombia
  • Europe
  • Canada
  • Italy
  • Oman
  • Poland
  • Switzerland
  • The UAE
  • The UK

Airway and Anesthesia Devices Pipeline Products Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • NMPA
  • UKCA
  • EUA
  • INVIMA
  • MDL

Scope

This report provides:

  • Extensive coverage of the Airway and Anesthesia Devices under development.
  • Details of major pipeline products which include product description, licensing, collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of Airway and Anesthesia Devices and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to the approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of Airway and Anesthesia Devices under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Adroit USA, Inc
Airway Innovations LLC
Cryofocus Medtech Shanghai Co Ltd
DMF Medical Inc
Drexel University
H. Lee Moffitt Cancer Center & Research Institute Inc
Johns Hopkins University
Medical Device Investments, Inc.
Rutgers The State University of New Jersey
Sedana Medical AB
Teleflex Inc
University of South Florida
Vida Medical Devices Inc
Vincent Medical Holdings Ltd
Wake Forest Baptist Medical Center
Xhale Inc

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Airway and Anesthesia Devices Overview

  • 3 Products under Development

    • 3.1 Airway and Anesthesia Devices – Pipeline Products by Stage of Development
    • 3.2 Airway and Anesthesia Devices – Pipeline Products by Territory
    • 3.3 Airway and Anesthesia Devices – Pipeline Products by Regulatory Path
    • 3.4 Airway and Anesthesia Devices – Pipeline Products by Estimated Approval Date
    • 3.5 Airway and Anesthesia Devices – Ongoing Clinical Trials

  • 4 Airway and Anesthesia Devices – Pipeline Products under Development by Companies

    • 4.1 Airway and Anesthesia Devices Companies – Pipeline Products by Stage of Development
    • 4.2 Airway and Anesthesia Devices – Pipeline Products by Stage of Development

  • 5 Airway and Anesthesia Devices Companies and Product Overview

    • 5.1 Adroit USA, Inc Company Overview

      • 5.1.1 Adroit USA, Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Airway Innovations LLC Company Overview

      • 5.2.1 Airway Innovations LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Cryofocus Medtech Shanghai Co Ltd Company Overview

      • 5.3.1 Cryofocus Medtech Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 DMF Medical Inc Company Overview

      • 5.4.1 DMF Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Drexel University Company Overview

      • 5.5.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview

      • 5.6.1 H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Johns Hopkins University Company Overview

      • 5.7.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Medical Device Investments, Inc. Company Overview

      • 5.8.1 Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Rutgers The State University of New Jersey Company Overview

      • 5.9.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Sedana Medical AB Company Overview

      • 5.10.1 Sedana Medical AB Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Teleflex Inc Company Overview

      • 5.11.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 University of South Florida Company Overview

      • 5.12.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Vida Medical Devices Inc Company Overview

      • 5.13.1 Vida Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Vincent Medical Holdings Ltd Company Overview

      • 5.14.1 Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Wake Forest Baptist Medical Center Company Overview

      • 5.15.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Xhale Inc Company Overview

      • 5.16.1 Xhale Inc Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Airway and Anesthesia Devices- Recent Developments

    • 6.1 Oct 28, 2022: Shandong Weigao Group Medical Polymer Co. Announces Resignation and Proposed Appointment of Independent Non-executive Directors
    • 6.2 Sep 19, 2022: Masimo names Blair Tripodi as COO for consumer division
    • 6.3 Sep 07, 2022: Baxter to Host Third-Quarter 2022 Financial Results Conference Call for Investors
    • 6.4 Sep 02, 2022: Shandong Weigao Group interim report 2022
    • 6.5 Sep 02, 2022: Shandong Weigao Group Medical Polymer Co. Notice of Extraordinary General Meeting
    • 6.6 Aug 22, 2022: Shandong Weigao Group Medical Polymer Co. Announces Interim Results for the Six Months Ended 30 June 2022
    • 6.7 Aug 22, 2022: Shandong Weigao Group Medical Polymer Co. Announces Resignation and Proposed Appointment of Independent Non-executive Directors
    • 6.8 Jul 22, 2022: Shandong Weigao Group Medical Polymer announce Change of Address of Hong Kong H Share Registrar and Transfer Office
    • 6.9 Jul 12, 2022: Aspire & USF Pass $10M in ticket & donation revenue
    • 6.10 Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors
    • 6.11 Jun 06, 2022: Shandong Weigao Group Medical Polymer Announce annual general meeting results
    • 6.12 May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
    • 6.13 May 10, 2022: Baxter to Host 2022 Investor Conference
    • 6.14 Apr 22, 2022: Shandong Weigao Group Medical Polymer Co. Announces Management Changes
    • 6.15 Apr 15, 2022: Shandong Weigao Group Medical Polymer Co. Announces Results for the Year Ended 31 December 2021
    • 6.16 Mar 24, 2022: Shandong Weigao Group Medical Polymer Annual Results Announcement For the Year Ended 31 December and Date of Board Meeting
    • 6.17 Feb 23, 2022: Shandong Weigao Orthopaedic Device announce preliminary results for the year ended 31 december 2021
    • 6.18 Feb 10, 2022: Baxter to Present at Citi’s 2022 Virtual Healthcare Conference
    • 6.19 Jan 31, 2022: Poly Medicure Announces Unaudited Financial Results for the Quarter and Nine Month Ended December 31 2021
    • 6.20 Jan 31, 2022: Poly Medicure Announces Statement of Unaudited Standalone Financial Results for the Quarter and Nine Months Ended December 31 2021
    • 6.21 Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Airway and Anesthesia Devices – Pipeline Products by Stage of Development 9

Airway and Anesthesia Devices – Pipeline Products by Territory 10

Airway and Anesthesia Devices – Pipeline Products by Regulatory Path 11

Airway and Anesthesia Devices – Pipeline Products by Estimated Approval Date 12

Airway and Anesthesia Devices – Ongoing Clinical Trials 13

Airway and Anesthesia Devices Companies – Pipeline Products by Stage of Development 14

Airway and Anesthesia Devices – Pipeline Products by Stage of Development 15

Adroit USA, Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Battery Powered Laryngoscope – Product Status 16

Battery Powered Laryngoscope – Product Description 16

Airway Innovations LLC Pipeline Products & Ongoing Clinical Trials Overview 17

Air Aid Endotracheal Tube Holder – Product Status 17

Air Aid Endotracheal Tube Holder – Product Description 17

Cryofocus Medtech Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

Tuberculosis Cryospray System – Product Status 18

Tuberculosis Cryospray System – Product Description 18

DMF Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Memsorb – Product Status 19

Memsorb – Product Description 19

DMF Medical Inc – Ongoing Clinical Trials Overview 20

Memsorb – A New and Innovative Method for CO2 Removal in Anesthetic Circuits 21

Memsorb – Decreasing Environmental Impact and Costs of Using Inhalational Anesthetics by Replacing Chemical Absorbers with an Innovative Carbon Dioxide Membrane Filter System – a Prospective, Randomized, Clinical Trial 21

Drexel University Pipeline Products & Ongoing Clinical Trials Overview 22

Ultrasound Guided Insertion Tube Monitor Device – Product Status 22

Ultrasound Guided Insertion Tube Monitor Device – Product Description 22

H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Improved Stylet – Endotracheal Tube Placement – Product Status 23

Improved Stylet – Endotracheal Tube Placement – Product Description 23

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 24

Tracheoesophageal Prosthesis Insufflator – Product Status 24

Tracheoesophageal Prosthesis Insufflator – Product Description 24

Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25

Anesthesia Intra-Oral Monitoring System – Product Status 25

Anesthesia Intra-Oral Monitoring System – Product Description 25

Orogastric Placement Intra-Oral Monitoring System – Product Status 25

Orogastric Placement Intra-Oral Monitoring System – Product Description 26

Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 27

Endotracheal Tube Placement Device – Product Status 27

Endotracheal Tube Placement Device – Product Description 27

Sedana Medical AB Pipeline Products & Ongoing Clinical Trials Overview 28

Sedaconda ACD – Product Status 28

Sedaconda ACD – Product Description 29

Sedana Medical AB – Ongoing Clinical Trials Overview 30

Sedaconda ACD – Evaluate the Incidence of Delirium in Mechanically Ventilated Intensive Care Patients Compared to Intravenous Sedation with Propofol 31

Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 32

ISO-Gard ClearAir Mask – Product Status 32

ISO-Gard ClearAir Mask – Product Description 33

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 34

Sensor Based Anesthesiology Measurement and Control System – Product Status 34

Sensor Based Anesthesiology Measurement and Control System – Product Description 34

Vida Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Hemoblocker – Product Status 35

Hemoblocker – Product Description 35

Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

LiqFree – Product Status 36

LiqFree – Product Description 36

Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 37

Endotracheal Tube Exchanger – Product Status 37

Endotracheal Tube Exchanger – Product Description 37

Locking Ventilation Bag – Product Status 38

Locking Ventilation Bag – Product Description 38

Xhale Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Assurance Pharmacodynamic Anesthesia Administration Monitor – Product Status 39

Assurance Pharmacodynamic Anesthesia Administration Monitor – Product Description 39

Glossary 58

Figures

Airway and Anesthesia Devices – Pipeline Products by Stage of Development 8

Airway and Anesthesia Devices – Pipeline Products by Territory 9

Airway and Anesthesia Devices – Pipeline Products by Regulatory Path 10

Airway and Anesthesia Devices – Pipeline Products by Estimated Approval Date 11

Airway and Anesthesia Devices – Ongoing Clinical Trials 12

Frequently asked questions

Airway and Anesthesia Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Airway and Anesthesia Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Airway and Anesthesia Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live Airway and Anesthesia Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.